The MM+M Podcast

The MM+M Podcast

MM+M editors Jameson Fleming, Jack O'Brien, Bella Czajkowski, Lecia Bushak, and Steve Madden speak with people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes released each week.

  1. Sep 16

    Spotlighting sickle cell disparities and rebranding Novo Nordisk to ‘Novo’

    Sickle cell disease has long been a frustrating medical condition impacting a historically overlooked patient population, but now there is something of a medical miracle treatment available.If only it were that simple.An estimated 100,000 Americans live with sickle cell disease, which disproportionately affects people of African descent. Roughly one in every 365 Black births in the U.S. is affected.In recognition of National Sickle Cell Awareness Month, Dr. Alana Arnold, a pediatric emergency physician and healthcare executive, and Akinwole Garrett, CEO of BlackDoctor, are on the podcast to discuss the systemic changes needed to improve patient outcomes.Editor-at-large Steve Madden helms a dual interview exploring the latest advancements in sickle cell disease treatment – namely the breakthrough CRISPR therapy Casgevy – as well as what has kept a medical miracle trapped behind systemic barriers.Arnold and Garrett hone in on the challenges of healthcare disparities and the systemic changes needed to improve outcomes in this particular patient community.For Trends, Madden and executive editor Jack O’Brien talk with reporter Bella Czajkowski about Novo Nordisk’s rebrand to “Novo” and how the Danish pharma giant can make the most of this moment for a cultural reset.  Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Spotlighting sickle cell disparities and rebranding Novo Nordisk to ‘Novo’
  2. Sep 10

    Former NFL star Kyle Long guards his mental health as part of J&J's Generation Fine

    The NFL season has kicked off, renewing focus on America’s most popular sport. While millions of people are eagerly tuning into the action on the gridiron, Johnson & Johnson is trying to focus some of that energy on people living with anxiety and depression. In May, the pharma giant launched Generation Fine, an initiative to normalize conversations regarding mental health, with a specific emphasis on major depressive disorder.  If there’s no crying in baseball, there’s even less in football – a sport defined by grit, toughness, never showing weakness and battling through constant, agonizing pain. That’s why J&J drafted Kyle Long, former NFL star and CBS Sports analyst, to dispel these longstanding misconceptions and encourage patients to get the behavioral care they need.Long, who has been public with his lifelong battles with anxiety and depression for more than a decade, joins executive editor Jack O’Brien for a special episode of the podcast to discuss his own patient journey, how he got involved in Generation Fine and what health brands to continue to improve the dialogue around mental health in America.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Former NFL star Kyle Long guards his mental health as part of J&J's Generation Fine
  3. Sep 9

    The most interesting man in medical marketing

    September 9, 2025 will go down as one of the most impactful days in the history of medical marketing. After months of saber rattling, the Trump administration announced that the FDA would crack down on DTC pharma ads on linear TV and social media.Yet September 9, 2025 wasn’t the apocalypse for medical marketing.Sure, there were days that turned into weeks of general unease and worry across the industry, but this is a resilient bunch. By the time we started conducting interviews with medical marketing shops for the 2026 Agency 100, most had gotten a handle on the situation and were baking in these challenges to their media plans and broader business strategies. Following editor-at-large Steve Madden’s feature interview with industry veteran Ritesh Patel, we’re looking back on the past 365 days. To mark the one-year anniversary of the start of the FDA’s pharma ad crackdown, executive editor Jack O’Brien joined by reporter Bella Czajkowski and pharma editor Lecia Bushak to talk about how the heightened regulatory focus has impacted pharma brands and their agency partners. Lecia also recently caught up with 4A’s Health Executive Director Jim Potter about what has changed since the crackdown began and where things go from here for the medical marketing community. You’ll get to hear some of his insights during the course of our conversation on then, now and what comes next.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    The most interesting man in medical marketing
  4. Sep 2

    What to expect at 2026 CMI Agility in Philadelphia

    Heading into Labor Day weekend, we’ve got a jumbo-packed two-fer episode, with both conversations centering around the number four. First up is an interview with CMI Media Group CEO and 2026 MM+M Woman of Distinction honoree Susan Dorfman as she previews the fourth edition of the CMI Agility conference in Philadelphia. Held on Monday, September 14, Agility serves as the Agency 100 honoree’s opportunity to urge the healthcare industry to move beyond simply focusing on "patient journey" and embrace more human-centered care. Susan is also joined by Mick Ebeling, founder of Not Impossible Labs, who is returning as a keynote speaker for the thought leadership summit. Ebeling is an out of the box thinker with a style that challenges many medical marketing conventions.  I think you’ll really enjoy hearing from him in conjunction with Susan’s updates on the WPP subsidiary as it heads into the final quarter of 2026. And in lieu of our Trends segment, we’re joined by Chris Fox, VP of marketing at Cleveland Diagnostics. Chris is on to discuss the return of the company’s PSA on PSA campaign for Prostate Cancer Awareness Month, why it’s critical to keep dismantling long-held stigmas surrounding prostate cancer care and survivorship, as well as how much that Novartis Super Bowl ad helped advance the cause of PSA screening.  Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    What to expect at 2026 CMI Agility in Philadelphia

Ratings & Reviews

4.2
out of 5
11 Ratings

About

MM+M editors Jameson Fleming, Jack O'Brien, Bella Czajkowski, Lecia Bushak, and Steve Madden speak with people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes released each week.